Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06257875
PHASE2

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). The purpose of this study is to assess how safe and effective lutikizumab is in adult participants with moderate to severe UC and how lutikizumab compares to adalimumab in the treatment of UC. Adverse events and changes in disease activity will be assessed. Lutikizumab is an investigational product being developed for the treatment of moderate to severe UC. Participants are placed in groups called treatment arms. Each group receives a different treatment. In the Induction Period, participants will be randomized into 1 of 3 arms receiving lutikizumab Dose 1, lutikizumab Dose 2, or adalimumab. In the Maintenance Period, participants who responded to lutikizumab will be randomized into 1 of 2 arms of lutikizumab maintenance and participants who responded to adalimumab will continue to receive adalimumab. All participants who did not achieve clinical response per modified Mayo Score at the end of the Induction period will receive lutikizumab. Around 200 adult participants with UC will be enrolled at approximately 200 sites worldwide. During the 12 week Induction Period, participants will be randomized to receive intravenous (IV) and subcutaneous (SC) lutikizumab or SC adalimumab. At the 12 week mark, participants who are on lutikizumab who have responded to treatment will be re-randomized to receive SC lutikizumab at different intervals until Week 52. Participants who are on adalimumab who are responding to treatment will continue to receive adalimumab. Participants who do not respond to treatment will receive SC lutikizumab. Participants who complete the Week 52 visit and in whom therapeutic benefit to study drug is confirmed by the investigator may roll over into an optional, 52-week long-term extension (LTE). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Official title: A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

156

Start Date

2024-03-23

Completion Date

2027-09

Last Updated

2025-10-07

Healthy Volunteers

No

Interventions

DRUG

Lutikizumab

Subcutaneous (SC) Injection

DRUG

Lutikizumab

Intravenous (IV) Infusion

DRUG

Adalimumab

SC Injection

Locations (191)

Gastro SB /ID# 258331

Chula Vista, California, United States

Southern California Res. Ctr. /ID# 258391

Coronado, California, United States

Newport Huntington Medical Group /ID# 258371

Huntington Beach, California, United States

Om Research LLC /ID# 261383

Lancaster, California, United States

UC Irvine Health /ID# 259824

Orange, California, United States

University of Colorado Hospital /ID# 258388

Aurora, Colorado, United States

Research Associates of South Florida, LLC /ID# 259813

Coral Gables, Florida, United States

University of Florida College of Medicine /ID# 260402

Gainesville, Florida, United States

Auzmer Research /ID# 260940

Lakeland, Florida, United States

Atlantic Medical Research /ID# 258507

Margate, Florida, United States

Homestead Associates in Research /ID# 260392

Miami, Florida, United States

University of Miami /ID# 258396

Miami, Florida, United States

JD Medical Group, LLC /ID# 261235

Miami, Florida, United States

Gastroenterology Group Naples /ID# 258346

Naples, Florida, United States

AdventHealth Medical Group Blood & Marrow Transplant at Orlando /ID# 260945

Orlando, Florida, United States

GCP Clinical Research, LLC /ID# 260401

Tampa, Florida, United States

Atlanta Ctr. for Gastro /ID# 259275

Decatur, Georgia, United States

Gastroenterology Associates of Central Georgia, LLC /ID# 258359

Macon, Georgia, United States

Gastroenterology Consultants, P.C /ID# 258352

Roswell, Georgia, United States

Northwestern Medicine - Northwestern Memorial Hospital /ID# 259592

Chicago, Illinois, United States

University of Chicago Medical Center /ID# 258491

Chicago, Illinois, United States

IU Health University Hospital /ID# 260398

Indianapolis, Indiana, United States

Univ Kansas Med Ctr /ID# 258489

Kansas City, Kansas, United States

Louisiana Research Center, LLC /ID# 258330

Shreveport, Louisiana, United States

Massachusetts General Hospital /Id# 259817

Boston, Massachusetts, United States

Clin Res Inst of Michigan, LLC /ID# 258386

Chesterfield, Michigan, United States

Clin Res Inst of Michigan, LLC /ID# 259267

Chesterfield, Michigan, United States

Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinic /ID# 258493

Wyoming, Michigan, United States

Mayo Clinic - Rochester /ID# 258402

Rochester, Minnesota, United States

Univ New Mexico /ID# 258490

Albuquerque, New Mexico, United States

NY Scientific /ID# 260937

Brooklyn, New York, United States

NYU Langone Long Island Clinical Research Associates /ID# 258504

Lake Success, New York, United States

Weill Cornell Medicine/NYP /ID# 258953

New York, New York, United States

Columbia University Medical Center /ID# 258496

New York, New York, United States

Atrium Health /ID# 258506

Charlotte, North Carolina, United States

DJL Clinical Research, PLLC /ID# 259465

Charlotte, North Carolina, United States

Atrium Health Wake Forest Baptist Medical Center /ID# 260387

Winston-Salem, North Carolina, United States

Plains Clinical Research Center, LLC /ID# 258502

Fargo, North Dakota, United States

Digestive Disease Specialists /ID# 258499

Oklahoma City, Oklahoma, United States

Digestive Health Associates of Texas (DHAT) Research Institute - Garland /ID# 258358

Garland, Texas, United States

Baylor College of Medicine /ID# 258394

Houston, Texas, United States

BioStar Clinical Research Group - Houston - Katy Freeway /ID# 261164

Houston, Texas, United States

Clinical Associates in Research Therapeutics of America, LLC /ID# 258403

San Antonio, Texas, United States

Southern Star Research Institute, LLC /ID# 258347

San Antonio, Texas, United States

Tyler Research Institute, LLC /ID# 258383

Tyler, Texas, United States

Texas Digestive Disease Consultants - Webster /ID# 258718

Webster, Texas, United States

University Physicians and Surgeons Inc. /ID# 260399

Huntington, West Virginia, United States

Wisconsin Center for Advanced Research /ID# 258949

Milwaukee, Wisconsin, United States

Bankstown-Lidcombe Hospital /ID# 259089

Bankstown, New South Wales, Australia

Lyell McEwin Hospital /ID# 260580

Elizabeth Vale, South Australia, Australia

The Queen Elizabeth Hospital /ID# 259482

Woodville South, South Australia, Australia

St Vincent's Hospital Melbourne /ID# 259473

Fitzroy Melbourne, Victoria, Australia

Fiona Stanley Hospital /ID# 259480

Murdoch, Western Australia, Australia

Universitaetsklinikum St. Poelten /ID# 258256

Sankt Pölten, Lower Austria, Austria

Medizinische Universitaet Wien /ID# 258026

Vienna, Vienna, Austria

Universite Libre de Bruxelles - Hopital Erasme /ID# 258214

Anderlecht, Brussels Capital, Belgium

UZ Gent /ID# 258210

Ghent, Oost-Vlaanderen, Belgium

Vitaz /Id# 258222

Sint-Niklaas, Oost-Vlaanderen, Belgium

Universitair Ziekenhuis Leuven /ID# 258226

Leuven, Vlaams-Brabant, Belgium

AZ Maria Middelares /ID# 258219

Ghent, Belgium

CHU de Liege /ID# 258212

Liège, Belgium

Hospital Tsaritsa Yoanna /ID# 258338

Sofiya, Sofia, Bulgaria

Medical Center - Doverie /ID# 261936

Sofiya, Sofia, Bulgaria

ACIBADEM City Clinic Diagnostic-Consultative Center /ID# 258339

Sofiya, Sofia, Bulgaria

Umbal Kaspela /ID# 258336

Plovdiv, Bulgaria

2nd Mhat /ID# 258337

Sofia, Bulgaria

UMHAT Sveti Ivan Rilski /ID# 261417

Sofia, Bulgaria

UMHAT Multiprofile Hospital for Active Treatment Sveta Marina /ID# 258878

Varna, Bulgaria

Gastroenterology and Internal Medicine Research Institution /ID# 258765

Edmonton, Alberta, Canada

Covenant Health /ID# 258799

Edmonton, Alberta, Canada

Toronto Digestive Disease Associates /ID# 260460

Vaughan, Ontario, Canada

Klinicki bolnicki centar Zagreb /ID# 258145

Zagreb, City of Zagreb, Croatia

Poliklinika Solmed /ID# 258147

Zagreb, City of Zagreb, Croatia

POLIKLINIKA BORZAN d.o.o. /ID# 258146

Osijek, County of Osijek-Baranja, Croatia

Specialty Hospital Medico /ID# 258169

Rijeka, Primorje-Gorski Kotar County, Croatia

Klinicki Bolnicki Centar (KBC) Split /ID# 258153

Split, Split-Dalmatia County, Croatia

West Tallinn Central Hospital /ID# 262035

Tallinn, Harju, Estonia

Medicum /ID# 268320

Tallinn, Harju, Estonia

Parnu Hospital /ID# 261783

Pärnu, Estonia

Tartu University Hospital /ID# 261782

Tartu, Estonia

Chu de Nice-Hopital L'Archet Ii /Id# 258041

Nice, Alpes-Maritimes, France

CHU Toulouse - Hopital Rangueil /ID# 258044

Toulouse, Haute-Garonne, France

Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 258555

Créteil, Paris, France

Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 258042

Nantes, Pays de la Loire Region, France

Centre Hospitalier Universitaire de Saint Etienne - Hopital Nord /ID# 258040

St-Priest-en-Jarez, Pays de la Loire Region, France

Universitaetsklinikum Ulm /ID# 258616

Ulm, Baden-Wurttemberg, Germany

Klinikum rechts der Isar /ID# 260228

Munich, Bavaria, Germany

St. Marien- und St. Annastiftskrankenhaus /ID# 264691

Ludwigshafen am Rhein, Rhineland-Palatinate, Germany

Eugastro /ID# 260229

Leipzig, Saxony, Germany

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 258614

Kiel, Schleswig-Holstein, Germany

Universitaetsklinikum Hamburg-Eppendorf /ID# 258617

Hamburg, Germany

General Hospital of Chest Diseases of Athens SOTIRIA /ID# 257831

Athens, Attica, Greece

University General Hospital of Heraklion PA.G.N.I /ID# 257832

Heraklion, Crete, Greece

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 257829

Athens, Greece

General Hospital of Thessaloniki Hippokrateio /ID# 260810

Thessaloniki, Greece

Clinfan /ID# 258094

Szekszárd, Tolna County, Hungary

Clinexpert Kft /ID# 258449

Budapest, Hungary

Synexus Hungary Clinical Research Centre - Budapest /ID# 258915

Budapest, Hungary

Semmelweis Egyetem /ID# 258527

Budapest, Hungary

Szegedi Tudományegyetem /ID# 258095

Szeged, Hungary

And 91 more locations on ClinicalTrials.gov